First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in aspergillus fumigatus isolates in the United States

Journal of Clinical Microbiology

Volumn 54, Issue 1, 2016, Pages 168-171

  Wiederhold, Nathan P ^a   Gil, Veronica Garcia ^b   Gutierrez, Felipe ^c,d   Lindner, Jonathan R ^a   Albataineh, Mohammad T ^a   McCarthy, Dora I ^a   Sanders, Carmita ^a   Fan, Hongxin ^a   Fothergill, Annette W ^a   Sutton, Deanna A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Phoenix VA Healthcare   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; FUNGAL PROTEIN; HISTIDINE; ISAVUCONAZOLE; ITRACONAZOLE; LEUCINE; PHENYLALANINE; POSACONAZOLE; PROTEIN TR34; PROTEIN TR46; STEROL 14ALPHA DEMETHYLASE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VORICONAZOLE; ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; UNITED STATES; ASPERGILLOSIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; STEROL 14-DEMETHYLASE; UNITED STATES;

EID: 84954310847     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02478-15     Document Type: Article

References (36)

1. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265-273. http://dx.doi.org/10.1086/595846.
2. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091-1100. http://dx.doi.org/10.1086/651263.
3. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG. 2010. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 50:1559-1567. http://dx.doi.org/10.1086/652768.
4. Smith NL, Denning DW. 2011. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37:865-872. http://dx.doi.org/10.1183/09031936.00054810.
5. Denning DW, Pleuvry A, Cole DC. 2011. Global burden of chronic pulmonary aspergillosisas asequelto pulmonary tuberculosis. Bull World Health Organ 89:864-872. http://dx.doi.org/10.2471/BLT.11.089441.
6. Denning DW, Pleuvry A, Cole DC. 2013. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J 41:621-626. http://dx.doi.org/10.1183/09031936.00226911.
7. Denning DW, Pleuvry A, Cole DC. 2013. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361-370. http://dx.doi.org/10.3109/13693786.2012.738312.
8. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15:1068-1076. http://dx.doi.org/10.3201/eid1507.090043.
9. Vermeulen E, Lagrou K, Verweij PE. 2013. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 26:493-500. http://dx.doi.org/10.1097/QCO.0000000000000005.
10. Seyedmousavi S, Mouton JW, Melchers WJ, Bruggemann RJ, Verweij PE. 2014. The role of azoles in the management of azole-resistant asper-gillosis: from the bench to the bedside. Drug Resist Updat 17:37-50. http://dx.doi.org/10.1016/j.drup.2014.06.001.
11. Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW. 2006. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 28:450-453. http://dx.doi.org/10.1016/j.ijantimicag.2006.08.017.
12. Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW. 2010. Azole antifungal resistance in Aspergillus fumiga-tus: 2008 and 2009. J Antimicrob Chemother 65:2116-2118. http://dx.doi.org/10.1093/jac/dkq279.
13. Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA. 2011. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 55:4465-4468. http://dx.doi.org/10.1128/AAC.00185-11.
14. Snelders E, Huis In 't Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE. 2009. Possible environmental origin of resistance of Aspergil-lus fumigatus to medical triazoles. Appl Environ Microbiol 75:4053-4057. http://dx.doi.org/10.1128/AEM.00231-09.
15. Hof H. 2008. Is there a serious risk of resistance development to azoles among fungi dueto the widespread use and long-term applicationofazole antifungals in medicine? Drug Resist Updat 11:25-31. http://dx.doi.org/10.1016/j.drup.2008.01.001.
16. 46/Y121F/T289A mutation in India. J Antimicrob Chemother 69:555-557. http://dx.doi.org/10.1093/jac/dkt397.
17. Verweij PE, Mellado E, Melchers WJ. 2007. Multiple-triazole-resistant aspergillosis. N Engl J Med 356:1481-1483. http://dx.doi.org/10.1056/NEJMc061720.
18. Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, Meis JF. 2014. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother 69:2979-2983. http://dx.doi.org/10.1093/jac/dku259.
19. 34/L98H mutations in the cyp51A gene in India. PLoS One 7:e52871. http://dx.doi.org/10.1371/journal.pone.0052871.
20. Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE. 2015. Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses 58:350-355. http://dx.doi.org/10.1111/myc.12324.
21. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219. http://dx.doi.org/10.1371/journal.pmed.0050219.
22. Pham CD, Reiss E, Hagen F, Meis JF, Lockhart SR. 2014. Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013. Emerg Infect Dis 20:1498-1503. http://dx.doi.org/10.3201/eid2009.140142.
23. CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
24. Verweij PE, Howard SJ, Melchers WJ, Denning DW. 2009. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 12:141-147. http://dx.doi.org/10.1016/j.drup.2009.09.002.
25. Glass NL, Donaldson GC. 1995. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomy-cetes. Appl Environ Microbiol 61:1323-1330.
26. Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J, Samson RA. 2007. Aspergillus species identification in the clinical setting. Stud Mycol 59:39-46. http://dx.doi.org/10.3114/sim.2007.59.05.
27. Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. 2001. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol 39:2431-2438. http://dx.doi.org/10.1128/JCM.39.7.2431-2438.2001.
28. Spiess B, Seifarth W, Merker N, Howard SJ, Reinwald M, Dietz A, Hofmann WK, Buchheidt D. 2012. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Anti-microb Agents Chemother 56:3905-3910. http://dx.doi.org/10.1128/AAC.05902-11.
29. TR34 L98H and TR46 Y121F T289A Mutations in the USA
30. Chen J, Li H, Li R, Bu D, Wan Z. 2005. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 55:31-37.
31. 34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment. Antimicrob Agents Chemother 58:5096-5101. http://dx.doi.org/10.1128/AAC.02855-14.
32. Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Møller N, Khan H, Melchers WJ, Verweij PE. 2010. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 5:e10080. http://dx.doi.org/10.1371/journal.pone.0010080.
33. Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, Ramage G, Denning DW, Bowyer P. 2013. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 68:1486-1496. http://dx.doi.org/10.1093/jac/dkt075.
34. Buied A, Moore CB, Denning DW, Bowyer P. 2013. High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. J Antimicrob Chemother 68:512-514. http://dx.doi.org/10.1093/jac/dks451.
35. da Silva Ferreira ME, Capellaro JL, dos Reis Marques E, Malavazi I, Perlin D, Park S, Anderson JB, Colombo AL, Arthington-Skaggs BA, Goldman MHS, Goldman GH. 2004. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother 48:4405-4413. http://dx.doi.org/10.1128/AAC.48.11.4405-4413.2004.
36. Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS. 2003. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 47:1719-1726. http://dx.doi.org/10.1128/AAC.47.5.1719-1726.2003.